Dr Reddys Laboratories Ltd Share Price Today - Live Blog for February 25, 2026

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.53%, reaching the current market price of 1307.10. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd witnessed a substantial 0.53% increase in its share price and is currently trading at 1307.10. This remarkable performance has caught the eye of investors.

The stock of Dr Reddys Laboratories Ltd suffered a -0.12% decline, and it currently trades at 1298.70 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd shares experienced a -0.12% reduction, with the current market price at 1298.70. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's stock has surged by 1.02%, and it is currently trading at 1313.40. Additionally, the stock maintains a PE ratio of 19.6400, while the industry PE is 32.1018.

Demonstrating a commendable 1.02% gain, Dr Reddys Laboratories Ltd's share price is currently situated at 1313.40. In terms of valuation, the stock maintains a PE ratio of 19.6400, while the industry PE ratio stands at 32.1018.

Dr Reddys Laboratories Ltd share price surged by 1.20%. With its current market price standing at 1315.80 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd observed a remarkable 1.20% surge in its share price and is presently trading at 1315.80. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd's stock price surged by 0.60%, reaching the current market value of 1308.00 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd observed a remarkable 0.60% surge in its share price and is presently trading at 1308.00. The increased investor interest is driving this surge.

The stock of Dr Reddys Laboratories Ltd suffered a -0.88% decline, and it currently trades at 1288.70 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd witnessed a -0.88% decrease in its share price, and it is currently trading at 1288.70. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.6400, an ROE of 16.0277 and a debt to equity ratio of 0.1625.